- Global Pharma News & Resources

General Anesthesia Drugs Market Growth, Trends, Absolute Opportunity and Value Chain 2021-2029 | Abbott Laboratories, AbbVie Inc., Astra Zeneca Plc & so on…

A new study of Future Market Insights (FMI) indicates that the global general anesthesia drugs market is poised for steady growth in the years ahead. Today, the general anesthesia drugs market remains driven by increased proportion of elderly patients and rising volume of surgical procedures; FMI analyst forecasts the market to witness 3.5% CAGR during the period, 2019-2029.

The general anesthesia drugs market is expected to be adversely impacted by the coronavirus outbreak. The pandemic has largely suspended anesthetic medical procedures, of a non-urgent nature, substantially reducing demand for general anesthesia drugs in the short term. Closure of clinics in nationwide lockdowns, and postponed elective medical procedures in the near future will hamper the general anesthesia drugs market. Recovery of the industry is dependent on the severity and duration of the disease.

“Tech advancements in drug delivery apparatus, research on patient monitoring devices, and targeted drugs for patients during and after the use of anesthesia, and reduction of side effects from modern anesthetic drugs are providing impetus to growth of the general anesthesia drugs market,” says the FMI analyst.

Request a sample of the report to gain in-depth market insights at

General Anesthesia Drugs Market – Key Takeaways

  • Propofol is a highly popular general anesthesia drug, aided by low risk of side effects.
  • Injectables remain the common general anesthesia drug delivery method, owing to superior efficacy properties.
  • Asia Pacific is a leading market for general anesthesia drugs, owing to rising demand for surgical intervention in chronic diseases such as diabetes.

General Anesthesia Drugs Market – Key Driving Factors

  • Rising cases of cardiovascular diseases is a key factor supporting the sales of general anesthesia drugs.
  • A rapidly ageing population with a wide range of chronic ailments generates demand for general anesthesia drugs.
  • Investments into research for drug delivery methods and drug formulations support market growth.

General Anesthesia Drugs Market – Key Constraints

  • Lack of standardization in terms of anesthesia management techniques hinders market developments.
  • High cost of branded anesthetics and associated medical procedures holds back market growth.

The Anticipated Impact of Coronavirus

Anesthetic practices have been substantially impacted by the coronavirus pandemic. Numerous clinics have had to suspend their operations, as elective medical procedures have been directed to be postponed. On the other hand, surgical interventions for aged covid-19 patients will generate opportunities, which will partially mitigate losses incurred during this crisis period.

Explore the global general anesthesia drugs market report with 75 illustrative figures, 41 data tables and the table of contents. You can also find a comprehensive market segmentation on

Competition Landscape

Players in the general anesthesia drugs market include but are not limited to Abbott Laboratories, AbbVie Inc., Astra Zeneca Plc, Baxter International Inc., and Fresenius SE & C. KGaA. Developers are investing in investing in research for product development, and wider scope of application. For instance, sevoflurane has been found to improve outcomes of patients with sepsis.

More About the Report

The FMI’s market research report offers detailed insights on general anesthesia drug s market. The market is scrutinized on the basis of drug class (propofol, sevoflurane, dexmedetomidine, desflurane, remifentanil, midazolam, and others), route of administration (intravenous anesthesia, and inhaled anesthesia), and end user (hospitals, ambulatory surgical centers, and specialty clinics) across seven key regions (North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa).


The global general anesthesia drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

By Drug Class

  • Propofol
  • Sevoflurane
  • Dexmedetomidine
  • Desflurane
  • Remifentanil
  • Midazolam
  • Others
  • (Others – Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental etc.)

By Route of Administration

  • Intravenous Anesthesia
  • Inhaled Anesthesia

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • MEA

Explore Extensive Coverage of FMI’s Healthcare, Pharmaceuticals, and Medical Devices Landscape

Porokeratosis treatment Market: Find insights on the lab automation market with segment analysis, statistics, influencing factors, and business strategies for a 10-year period.

Lung Cancer Surgery Market: FMI’s report on the lung cancer surgery market offers details on the market set for 2019-2029. The study includes impacting forces, sources of revenue, market leaders, and important strategies.

Veterinary Vaccines Market: Get an in-depth analysis on the veterinary vaccines market with insights on growth factors, opportunities, regulatory policies, restraints, regional markets and market leaders.

About us 

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact us

Mr. Abhishek Budholiya
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries:
For Media Enquiries:

Editor Details

Last Updated: 14-Apr-2021